Echo Therapeutics (ECTE) Gets Patent Allowance for Prelude SkinPrep System

Article Stock Quotes (1) Comments (0)

Echo Therapeutics, Inc. (Nasdaq: ECTE), announced the receipt of a notice of allowance for a patent application covering its Prelude SkinPrep System and a notice of issuance for a patent covering its Symphony tCGM System.

Echo Therapeutics received notice that its U.S. Patent Application No. 10/792,862 entitled "Method and Apparatus for Enhancement of Transdermal Transport" has been allowed. Echo Therapeutics also received notice that its patent application entitled "Transdermal Analyte Monitoring Systems and Methods for Analyte Detection" issued as Russian Patent No. 2444980 and will expire in 2028 if all maintenance fees are timely paid.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Novo Nordisk (NVO) Reports Positive Results from Paradigm 2
• St. Jude (STJ) Receives CE Mark for LUMIEN OPTIS PCI System
• Alnylam (ALNY) Updates on Preclinical Data for RNAi Program Targeting ALAS-1

Create E-mail Alert Related Categories

Corporate News, FDA

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?